Pulmonx Corp (FRA:4NI)

Q2 2025 Pulmonx Corp Earnings Call Transcript

Jul 30, 2025 / 08:30 PM GMT

Release Date Price: €2.62

Transcript 10-Q8-K

Key Points

Positve

Pulmonx Corp (LUNG) reported a 15% increase in total worldwide revenue for Q2 2025, reaching $23.9 million, indicating strong adoption of their Zephyr valves.
International revenue excelled, achieving a record $9.1 million, a 32% increase from the previous year, showcasing robust demand and effective global commercial execution.
The company has launched successful direct-to-patient campaigns, expecting to exceed 70,000 first-time patient engagements this year, significantly driving patient inquiries and website traffic.
Pulmonx Corp (LUNG) is making progress with its AI-powered screening tool, Lung Track Detect, which has shown promising early results in identifying emphysema patients from routine CT scans.
The company is expanding its capacity footprint, having opened 12 new screening centers and trained 26 new physicians in Q2 alone, enhancing patient access and treatment capacity.

Negative

US revenue growth was slower than expected, with Q2 2025 revenue at $14.7 million, reflecting operational pressures and capacity constraints at interventional pulmonology centers.
Pulmonx Corp (LUNG) revised its full-year 2025 revenue guidance down from $96-$98 million to $90-$92 million due to slower-than-anticipated ramp-up of US commercial initiatives.
The company faced a decline in Stratex scans, a leading indicator for their procedures, due to capacity constraints and evolving priorities within IP centers.
Gross margin for Q2 2025 decreased to 72% from 74% in the previous year, primarily due to a shift in geographic revenue mix with a larger share from international markets.
Net loss for Q2 2025 was $15.2 million, slightly improved from a $15.3 million loss in the prior year, but still indicating ongoing financial challenges.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

LUNG.OQ - Pulmonx Corp
Q2 2025 Pulmonx Corp Earnings Call
Jul 30, 2025 / 08:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Ladies and gentlemen, thank you for standing by, and welcome to Pullmonic's 2nd quarter, 2025 financial results conference call. At this time, all participants are on a listen-only mode. After the speaker's presentation, there will be a question and answer session.

Please be advised that today's conference is being recorded.

I would now like to turn the conference over to Jeremy Pfeffer of Lifestyle Advisors Investor Relations. Please go ahead.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Good afternoon and thank you all for participating in today's call. Joining me from

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.